Circulating	O
Memory	B:C0039215
CD4	I:C0039215
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
Target	O
Conserved	O
Epitopes	O
of	O
Rhinovirus	O
Capsid	O
Proteins	I:C1136102
and	O
Respond	O
Rapidly	O
to	O
Experimental	O
Infection	O
in	O
Humans	O
.	O

Circulating	O
Memory	O
CD4	I:C0039215
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
Target	O
Conserved	O
Epitopes	B:C0003316
of	O
Rhinovirus	O
Capsid	O
Proteins	I:C1136102
and	O
Respond	O
Rapidly	O
to	O
Experimental	O
Infection	O
in	O
Humans	O
.	O

Circulating	O
Memory	O
CD4	I:C0039215
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
Target	O
Conserved	O
Epitopes	O
of	O
Rhinovirus	B:C0035473
Capsid	O
Proteins	I:C1136102
and	O
Respond	O
Rapidly	O
to	O
Experimental	O
Infection	O
in	O
Humans	O
.	O

Circulating	O
Memory	O
CD4	I:C0039215
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
Target	O
Conserved	O
Epitopes	O
of	O
Rhinovirus	O
Capsid	B:C1136102
Proteins	I:C1136102
and	O
Respond	O
Rapidly	O
to	O
Experimental	O
Infection	O
in	O
Humans	O
.	O

Circulating	O
Memory	O
CD4	I:C0039215
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
Target	O
Conserved	O
Epitopes	O
of	O
Rhinovirus	O
Capsid	O
Proteins	I:C1136102
and	O
Respond	O
Rapidly	O
to	O
Experimental	O
Infection	B:C3714514
in	O
Humans	O
.	O

Circulating	O
Memory	O
CD4	I:C0039215
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
Target	O
Conserved	O
Epitopes	O
of	O
Rhinovirus	O
Capsid	O
Proteins	I:C1136102
and	O
Respond	O
Rapidly	O
to	O
Experimental	O
Infection	O
in	O
Humans	B:C0086418
.	O

Rhinovirus	B:C0035473
(	O
Rhinovirus	O
)	O
is	O
a	O
major	O
cause	O
of	O
common	O
cold	I:C0009443
and	O
an	O
important	O
trigger	O
of	O
acute	O
episodes	O
of	O
chronic	O
lung	I:C0746102
diseases	I:C0746102
.	O

Rhinovirus	O
(	O
Rhinovirus	B:C0035473
)	O
is	O
a	O
major	O
cause	O
of	O
common	O
cold	I:C0009443
and	O
an	O
important	O
trigger	O
of	O
acute	O
episodes	O
of	O
chronic	O
lung	I:C0746102
diseases	I:C0746102
.	O

Rhinovirus	O
(	O
Rhinovirus	O
)	O
is	O
a	O
major	O
cause	O
of	O
common	B:C0009443
cold	I:C0009443
and	O
an	O
important	O
trigger	O
of	O
acute	O
episodes	O
of	O
chronic	O
lung	I:C0746102
diseases	I:C0746102
.	O

Rhinovirus	O
(	O
Rhinovirus	O
)	O
is	O
a	O
major	O
cause	O
of	O
common	O
cold	I:C0009443
and	O
an	O
important	O
trigger	O
of	O
acute	O
episodes	O
of	O
chronic	B:C0746102
lung	I:C0746102
diseases	I:C0746102
.	O

Antigenic	B:C0003319
variation	I:C0003319
across	O
the	O
numerous	O
RV	O
strains	I:C0035473
results	O
in	O
frequent	O
infections	O
and	O
a	O
lack	O
of	O
durable	O
cross-protection	O
.	O

Antigenic	O
variation	I:C0003319
across	O
the	O
numerous	O
RV	B:C0035473
strains	I:C0035473
results	O
in	O
frequent	O
infections	O
and	O
a	O
lack	O
of	O
durable	O
cross-protection	O
.	O

Antigenic	O
variation	I:C0003319
across	O
the	O
numerous	O
RV	O
strains	I:C0035473
results	O
in	O
frequent	O
infections	B:C3714514
and	O
a	O
lack	O
of	O
durable	O
cross-protection	O
.	O

Antigenic	O
variation	I:C0003319
across	O
the	O
numerous	O
RV	O
strains	I:C0035473
results	O
in	O
frequent	O
infections	O
and	O
a	O
lack	O
of	O
durable	O
cross-protection	B:C2717886
.	O

Because	O
the	O
nature	O
of	O
human	B:C0086418
CD4	O
(+	I:C0039215
)	I:C0039215

Because	O
the	O
nature	O
of	O
human	O
CD4	B:C0039215
(+	I:C0039215
)	I:C0039215

T	I:C0039215
cells	I:C0039215
that	O
target	O
Rhinovirus	B:C0035473
is	O
largely	O
unknown	O
,	O
T	O
cell	I:C0282580
epitopes	I:C0282580
of	O
Rhinovirus	O
capsid	O
proteins	I:C1136102
were	O
analyzed	O
,	O
and	O
cognate	O
T	O
cells	I:C0039194
were	O
characterized	O
in	O
healthy	O
subjects	I:C1708335
and	O
those	O
infected	O
by	O
intranasal	O
challenge	I:C0001560
.	O

T	I:C0039215
cells	I:C0039215
that	O
target	O
Rhinovirus	O
is	O
largely	O
unknown	O
,	O
T	B:C0282580
cell	I:C0282580
epitopes	I:C0282580
of	O
Rhinovirus	O
capsid	O
proteins	I:C1136102
were	O
analyzed	O
,	O
and	O
cognate	O
T	O
cells	I:C0039194
were	O
characterized	O
in	O
healthy	O
subjects	I:C1708335
and	O
those	O
infected	O
by	O
intranasal	O
challenge	I:C0001560
.	O

T	I:C0039215
cells	I:C0039215
that	O
target	O
Rhinovirus	O
is	O
largely	O
unknown	O
,	O
T	O
cell	I:C0282580
epitopes	I:C0282580
of	O
Rhinovirus	B:C0035473
capsid	O
proteins	I:C1136102
were	O
analyzed	O
,	O
and	O
cognate	O
T	O
cells	I:C0039194
were	O
characterized	O
in	O
healthy	O
subjects	I:C1708335
and	O
those	O
infected	O
by	O
intranasal	O
challenge	I:C0001560
.	O

T	I:C0039215
cells	I:C0039215
that	O
target	O
Rhinovirus	O
is	O
largely	O
unknown	O
,	O
T	O
cell	I:C0282580
epitopes	I:C0282580
of	O
Rhinovirus	O
capsid	B:C1136102
proteins	I:C1136102
were	O
analyzed	O
,	O
and	O
cognate	O
T	O
cells	I:C0039194
were	O
characterized	O
in	O
healthy	O
subjects	I:C1708335
and	O
those	O
infected	O
by	O
intranasal	O
challenge	I:C0001560
.	O

T	I:C0039215
cells	I:C0039215
that	O
target	O
Rhinovirus	O
is	O
largely	O
unknown	O
,	O
T	O
cell	I:C0282580
epitopes	I:C0282580
of	O
Rhinovirus	O
capsid	O
proteins	I:C1136102
were	O
analyzed	O
,	O
and	O
cognate	O
T	B:C0039194
cells	I:C0039194
were	O
characterized	O
in	O
healthy	O
subjects	I:C1708335
and	O
those	O
infected	O
by	O
intranasal	O
challenge	I:C0001560
.	O

T	I:C0039215
cells	I:C0039215
that	O
target	O
Rhinovirus	O
is	O
largely	O
unknown	O
,	O
T	O
cell	I:C0282580
epitopes	I:C0282580
of	O
Rhinovirus	O
capsid	O
proteins	I:C1136102
were	O
analyzed	O
,	O
and	O
cognate	O
T	O
cells	I:C0039194
were	O
characterized	O
in	O
healthy	B:C1708335
subjects	I:C1708335
and	O
those	O
infected	O
by	O
intranasal	O
challenge	I:C0001560
.	O

T	I:C0039215
cells	I:C0039215
that	O
target	O
Rhinovirus	O
is	O
largely	O
unknown	O
,	O
T	O
cell	I:C0282580
epitopes	I:C0282580
of	O
Rhinovirus	O
capsid	O
proteins	I:C1136102
were	O
analyzed	O
,	O
and	O
cognate	O
T	O
cells	I:C0039194
were	O
characterized	O
in	O
healthy	O
subjects	I:C1708335
and	O
those	O
infected	B:C0439663
by	O
intranasal	O
challenge	I:C0001560
.	O

T	I:C0039215
cells	I:C0039215
that	O
target	O
Rhinovirus	O
is	O
largely	O
unknown	O
,	O
T	O
cell	I:C0282580
epitopes	I:C0282580
of	O
Rhinovirus	O
capsid	O
proteins	I:C1136102
were	O
analyzed	O
,	O
and	O
cognate	O
T	O
cells	I:C0039194
were	O
characterized	O
in	O
healthy	O
subjects	I:C1708335
and	O
those	O
infected	O
by	O
intranasal	B:C0001560
challenge	I:C0001560
.	O

Peptide	B:C0030956
epitopes	O
of	O
the	O
RV	O
-	I:C0318483
A16	I:C0318483
capsid	O
proteins	I:C1136102
VP1	O
and	O
VP2	O
were	O
identified	O
by	O
peptide	O
/	O
MHC	O
class	I:C0019630
II	I:C0019630
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
,	O
validated	O
by	O
direct	O
ex	O
vivo	O
enumeration	O
,	O
and	O
interrogated	O
using	O
a	O
variety	O
of	O
in	O
silico	O
methods	O
.	O

Peptide	O
epitopes	B:C0003316
of	O
the	O
RV	O
-	I:C0318483
A16	I:C0318483
capsid	O
proteins	I:C1136102
VP1	O
and	O
VP2	O
were	O
identified	O
by	O
peptide	O
/	O
MHC	O
class	I:C0019630
II	I:C0019630
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
,	O
validated	O
by	O
direct	O
ex	O
vivo	O
enumeration	O
,	O
and	O
interrogated	O
using	O
a	O
variety	O
of	O
in	O
silico	O
methods	O
.	O

Peptide	O
epitopes	O
of	O
the	O
RV	B:C0318483
-	I:C0318483
A16	I:C0318483
capsid	O
proteins	I:C1136102
VP1	O
and	O
VP2	O
were	O
identified	O
by	O
peptide	O
/	O
MHC	O
class	I:C0019630
II	I:C0019630
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
,	O
validated	O
by	O
direct	O
ex	O
vivo	O
enumeration	O
,	O
and	O
interrogated	O
using	O
a	O
variety	O
of	O
in	O
silico	O
methods	O
.	O

Peptide	O
epitopes	O
of	O
the	O
RV	O
-	I:C0318483
A16	I:C0318483
capsid	B:C1136102
proteins	I:C1136102
VP1	O
and	O
VP2	O
were	O
identified	O
by	O
peptide	O
/	O
MHC	O
class	I:C0019630
II	I:C0019630
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
,	O
validated	O
by	O
direct	O
ex	O
vivo	O
enumeration	O
,	O
and	O
interrogated	O
using	O
a	O
variety	O
of	O
in	O
silico	O
methods	O
.	O

Peptide	O
epitopes	O
of	O
the	O
RV	O
-	I:C0318483
A16	I:C0318483
capsid	O
proteins	I:C1136102
VP1	B:C0168985
and	O
VP2	O
were	O
identified	O
by	O
peptide	O
/	O
MHC	O
class	I:C0019630
II	I:C0019630
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
,	O
validated	O
by	O
direct	O
ex	O
vivo	O
enumeration	O
,	O
and	O
interrogated	O
using	O
a	O
variety	O
of	O
in	O
silico	O
methods	O
.	O

Peptide	O
epitopes	O
of	O
the	O
RV	O
-	I:C0318483
A16	I:C0318483
capsid	O
proteins	I:C1136102
VP1	O
and	O
VP2	B:C0208912
were	O
identified	O
by	O
peptide	O
/	O
MHC	O
class	I:C0019630
II	I:C0019630
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
,	O
validated	O
by	O
direct	O
ex	O
vivo	O
enumeration	O
,	O
and	O
interrogated	O
using	O
a	O
variety	O
of	O
in	O
silico	O
methods	O
.	O

Peptide	O
epitopes	O
of	O
the	O
RV	O
-	I:C0318483
A16	I:C0318483
capsid	O
proteins	I:C1136102
VP1	O
and	O
VP2	O
were	O
identified	O
by	O
peptide	B:C0030956
/	O
MHC	O
class	I:C0019630
II	I:C0019630
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
,	O
validated	O
by	O
direct	O
ex	O
vivo	O
enumeration	O
,	O
and	O
interrogated	O
using	O
a	O
variety	O
of	O
in	O
silico	O
methods	O
.	O

Peptide	O
epitopes	O
of	O
the	O
RV	O
-	I:C0318483
A16	I:C0318483
capsid	O
proteins	I:C1136102
VP1	O
and	O
VP2	O
were	O
identified	O
by	O
peptide	O
/	O
MHC	B:C0019630
class	I:C0019630
II	I:C0019630
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
,	O
validated	O
by	O
direct	O
ex	O
vivo	O
enumeration	O
,	O
and	O
interrogated	O
using	O
a	O
variety	O
of	O
in	O
silico	O
methods	O
.	O

Peptide	O
epitopes	O
of	O
the	O
RV	O
-	I:C0318483
A16	I:C0318483
capsid	O
proteins	I:C1136102
VP1	O
and	O
VP2	O
were	O
identified	O
by	O
peptide	O
/	O
MHC	O
class	I:C0019630
II	I:C0019630
tetramer	B:C0242831
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
,	O
validated	O
by	O
direct	O
ex	O
vivo	O
enumeration	O
,	O
and	O
interrogated	O
using	O
a	O
variety	O
of	O
in	O
silico	O
methods	O
.	O

Among	O
noninfected	B:C1708335
subjects	I:C1708335
,	O
those	O
circulating	O
RV	O
-	I:C0318483
A16	I:C0318483
-	O
specific	O
CD4	O
(+	I:C0039215
)	I:C0039215

Among	O
noninfected	O
subjects	I:C1708335
,	O
those	O
circulating	O
RV	B:C0318483
-	I:C0318483
A16	I:C0318483
-	O
specific	O
CD4	O
(+	I:C0039215
)	I:C0039215

Among	O
noninfected	O
subjects	I:C1708335
,	O
those	O
circulating	O
RV	O
-	I:C0318483
A16	I:C0318483
-	O
specific	O
CD4	B:C0039215
(+	I:C0039215
)	I:C0039215

T	I:C0039215
cells	I:C0039215
detected	O
at	O
the	O
highest	O
frequencies	O
targeted	O
10	O
unique	O
epitopes	B:C0003316
that	O
bound	O
to	O
diverse	O
HLA	O
-	I:C0019764
DR	I:C0019764
molecules	O
.	O

T	I:C0039215
cells	I:C0039215
detected	O
at	O
the	O
highest	O
frequencies	O
targeted	O
10	O
unique	O
epitopes	O
that	O
bound	O
to	O
diverse	O
HLA	B:C0019764
-	I:C0019764
DR	I:C0019764
molecules	O
.	O

T	B:C0282580
cell	I:C0282580
epitopes	I:C0282580
localized	O
to	O
conserved	O
molecular	I:C0009802
regions	I:C0009802
of	O
biological	O
significance	O
to	O
the	O
virus	O
were	O
enriched	O
for	O
HLA	O
class	O
I	O
and	O
II	O
binding	O
motifs	O
,	O
and	O
constituted	O
both	O
species	O
-	O
specific	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
)	O
and	O
pan-species	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
,	O
-	O
B	O
,	O
and	O
-	O
C	O
)	O
varieties	O
.	O

T	O
cell	I:C0282580
epitopes	I:C0282580
localized	O
to	O
conserved	B:C0009802
molecular	I:C0009802
regions	I:C0009802
of	O
biological	O
significance	O
to	O
the	O
virus	O
were	O
enriched	O
for	O
HLA	O
class	O
I	O
and	O
II	O
binding	O
motifs	O
,	O
and	O
constituted	O
both	O
species	O
-	O
specific	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
)	O
and	O
pan-species	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
,	O
-	O
B	O
,	O
and	O
-	O
C	O
)	O
varieties	O
.	O

T	O
cell	I:C0282580
epitopes	I:C0282580
localized	O
to	O
conserved	O
molecular	I:C0009802
regions	I:C0009802
of	O
biological	O
significance	O
to	O
the	O
virus	B:C0042776
were	O
enriched	O
for	O
HLA	O
class	O
I	O
and	O
II	O
binding	O
motifs	O
,	O
and	O
constituted	O
both	O
species	O
-	O
specific	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
)	O
and	O
pan-species	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
,	O
-	O
B	O
,	O
and	O
-	O
C	O
)	O
varieties	O
.	O

T	O
cell	I:C0282580
epitopes	I:C0282580
localized	O
to	O
conserved	O
molecular	I:C0009802
regions	I:C0009802
of	O
biological	O
significance	O
to	O
the	O
virus	O
were	O
enriched	O
for	O
HLA	O
class	O
I	O
and	O
II	O
binding	O
motifs	O
,	O
and	O
constituted	O
both	O
species	B:C1705920
-	O
specific	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
)	O
and	O
pan-species	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
,	O
-	O
B	O
,	O
and	O
-	O
C	O
)	O
varieties	O
.	O

T	O
cell	I:C0282580
epitopes	I:C0282580
localized	O
to	O
conserved	O
molecular	I:C0009802
regions	I:C0009802
of	O
biological	O
significance	O
to	O
the	O
virus	O
were	O
enriched	O
for	O
HLA	O
class	O
I	O
and	O
II	O
binding	O
motifs	O
,	O
and	O
constituted	O
both	O
species	O
-	O
specific	O
(	O
RV	B:C1071061
-	I:C1071061
A	I:C1071061
)	O
and	O
pan-species	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
,	O
-	O
B	O
,	O
and	O
-	O
C	O
)	O
varieties	O
.	O

T	O
cell	I:C0282580
epitopes	I:C0282580
localized	O
to	O
conserved	O
molecular	I:C0009802
regions	I:C0009802
of	O
biological	O
significance	O
to	O
the	O
virus	O
were	O
enriched	O
for	O
HLA	O
class	O
I	O
and	O
II	O
binding	O
motifs	O
,	O
and	O
constituted	O
both	O
species	O
-	O
specific	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
)	O
and	O
pan-species	B:C0008111
(	O
RV	O
-	I:C1071061
A	I:C1071061
,	O
-	O
B	O
,	O
and	O
-	O
C	O
)	O
varieties	O
.	O

T	O
cell	I:C0282580
epitopes	I:C0282580
localized	O
to	O
conserved	O
molecular	I:C0009802
regions	I:C0009802
of	O
biological	O
significance	O
to	O
the	O
virus	O
were	O
enriched	O
for	O
HLA	O
class	O
I	O
and	O
II	O
binding	O
motifs	O
,	O
and	O
constituted	O
both	O
species	O
-	O
specific	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
)	O
and	O
pan-species	O
(	O
RV	B:C1071061
-	I:C1071061
A	I:C1071061
,	O
-	O
B	O
,	O
and	O
-	O
C	O
)	O
varieties	O
.	O

T	O
cell	I:C0282580
epitopes	I:C0282580
localized	O
to	O
conserved	O
molecular	I:C0009802
regions	I:C0009802
of	O
biological	O
significance	O
to	O
the	O
virus	O
were	O
enriched	O
for	O
HLA	O
class	O
I	O
and	O
II	O
binding	O
motifs	O
,	O
and	O
constituted	O
both	O
species	O
-	O
specific	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
)	O
and	O
pan-species	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
,	O
-	O
B	B:C1071062
,	O
and	O
-	O
C	O
)	O
varieties	O
.	O

T	O
cell	I:C0282580
epitopes	I:C0282580
localized	O
to	O
conserved	O
molecular	I:C0009802
regions	I:C0009802
of	O
biological	O
significance	O
to	O
the	O
virus	O
were	O
enriched	O
for	O
HLA	O
class	O
I	O
and	O
II	O
binding	O
motifs	O
,	O
and	O
constituted	O
both	O
species	O
-	O
specific	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
)	O
and	O
pan-species	O
(	O
RV	O
-	I:C1071061
A	I:C1071061
,	O
-	O
B	O
,	O
and	O
-	O
C	B:C2290915
)	O
varieties	O
.	O

Circulating	O
epitope	B:C0003316
-	O
specific	O
T	O
cells	I:C0039194
comprised	O
both	O
memory	O
Th1	I:C0242632
and	O
T	O
follicular	I:C0018894
helper	I:C0018894
cells	I:C0018894
,	O
and	O
were	O
rapidly	O
expanded	O
and	O
activated	O
after	O
intranasal	O
challenge	I:C0001560
with	O
RV	O
-	I:C0318483
A16	I:C0318483
.	O

Circulating	O
epitope	O
-	O
specific	O
T	B:C0039194
cells	I:C0039194
comprised	O
both	O
memory	O
Th1	I:C0242632
and	O
T	O
follicular	I:C0018894
helper	I:C0018894
cells	I:C0018894
,	O
and	O
were	O
rapidly	O
expanded	O
and	O
activated	O
after	O
intranasal	O
challenge	I:C0001560
with	O
RV	O
-	I:C0318483
A16	I:C0318483
.	O

Circulating	O
epitope	O
-	O
specific	O
T	O
cells	I:C0039194
comprised	O
both	O
memory	B:C0242632
Th1	I:C0242632
and	O
T	O
follicular	I:C0018894
helper	I:C0018894
cells	I:C0018894
,	O
and	O
were	O
rapidly	O
expanded	O
and	O
activated	O
after	O
intranasal	O
challenge	I:C0001560
with	O
RV	O
-	I:C0318483
A16	I:C0318483
.	O

Circulating	O
epitope	O
-	O
specific	O
T	O
cells	I:C0039194
comprised	O
both	O
memory	O
Th1	I:C0242632
and	O
T	B:C0018894
follicular	I:C0018894
helper	I:C0018894
cells	I:C0018894
,	O
and	O
were	O
rapidly	O
expanded	O
and	O
activated	O
after	O
intranasal	O
challenge	I:C0001560
with	O
RV	O
-	I:C0318483
A16	I:C0318483
.	O

Circulating	O
epitope	O
-	O
specific	O
T	O
cells	I:C0039194
comprised	O
both	O
memory	O
Th1	I:C0242632
and	O
T	O
follicular	I:C0018894
helper	I:C0018894
cells	I:C0018894
,	O
and	O
were	O
rapidly	O
expanded	O
and	O
activated	O
after	O
intranasal	B:C0001560
challenge	I:C0001560
with	O
RV	O
-	I:C0318483
A16	I:C0318483
.	O

Circulating	O
epitope	O
-	O
specific	O
T	O
cells	I:C0039194
comprised	O
both	O
memory	O
Th1	I:C0242632
and	O
T	O
follicular	I:C0018894
helper	I:C0018894
cells	I:C0018894
,	O
and	O
were	O
rapidly	O
expanded	O
and	O
activated	O
after	O
intranasal	O
challenge	I:C0001560
with	O
RV	B:C0318483
-	I:C0318483
A16	I:C0318483
.	O

Cross-reactivity	O
was	O
evidenced	O
by	O
identification	O
of	O
a	O
common	O
*	O
0401	O
-	O
restricted	B:C0003316
epitope	I:C0003316
for	O
RV	O
-	I:C0318483
A16	I:C0318483
and	O
RV	O
-	I:C0318506
A39	I:C0318506
by	O
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
and	O
the	O
ability	O
for	O
RV	O
-	I:C0318483
A16	I:C0318483
-	O
specific	O
Th1	O
cells	I:C0242632
to	O
proliferate	O
in	O
response	O
to	O
their	O
RV	O
-	I:C0318506
A39	I:C0318506
peptide	O
counterpart	O
.	O

Cross-reactivity	O
was	O
evidenced	O
by	O
identification	O
of	O
a	O
common	O
*	O
0401	O
-	O
restricted	O
epitope	I:C0003316
for	O
RV	B:C0318483
-	I:C0318483
A16	I:C0318483
and	O
RV	O
-	I:C0318506
A39	I:C0318506
by	O
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
and	O
the	O
ability	O
for	O
RV	O
-	I:C0318483
A16	I:C0318483
-	O
specific	O
Th1	O
cells	I:C0242632
to	O
proliferate	O
in	O
response	O
to	O
their	O
RV	O
-	I:C0318506
A39	I:C0318506
peptide	O
counterpart	O
.	O

Cross-reactivity	O
was	O
evidenced	O
by	O
identification	O
of	O
a	O
common	O
*	O
0401	O
-	O
restricted	O
epitope	I:C0003316
for	O
RV	O
-	I:C0318483
A16	I:C0318483
and	O
RV	B:C0318506
-	I:C0318506
A39	I:C0318506
by	O
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
and	O
the	O
ability	O
for	O
RV	O
-	I:C0318483
A16	I:C0318483
-	O
specific	O
Th1	O
cells	I:C0242632
to	O
proliferate	O
in	O
response	O
to	O
their	O
RV	O
-	I:C0318506
A39	I:C0318506
peptide	O
counterpart	O
.	O

Cross-reactivity	O
was	O
evidenced	O
by	O
identification	O
of	O
a	O
common	O
*	O
0401	O
-	O
restricted	O
epitope	I:C0003316
for	O
RV	O
-	I:C0318483
A16	I:C0318483
and	O
RV	O
-	I:C0318506
A39	I:C0318506
by	O
tetramer	B:C0242831
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
and	O
the	O
ability	O
for	O
RV	O
-	I:C0318483
A16	I:C0318483
-	O
specific	O
Th1	O
cells	I:C0242632
to	O
proliferate	O
in	O
response	O
to	O
their	O
RV	O
-	I:C0318506
A39	I:C0318506
peptide	O
counterpart	O
.	O

Cross-reactivity	O
was	O
evidenced	O
by	O
identification	O
of	O
a	O
common	O
*	O
0401	O
-	O
restricted	O
epitope	I:C0003316
for	O
RV	O
-	I:C0318483
A16	I:C0318483
and	O
RV	O
-	I:C0318506
A39	I:C0318506
by	O
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
and	O
the	O
ability	O
for	O
RV	B:C0318483
-	I:C0318483
A16	I:C0318483
-	O
specific	O
Th1	O
cells	I:C0242632
to	O
proliferate	O
in	O
response	O
to	O
their	O
RV	O
-	I:C0318506
A39	I:C0318506
peptide	O
counterpart	O
.	O

Cross-reactivity	O
was	O
evidenced	O
by	O
identification	O
of	O
a	O
common	O
*	O
0401	O
-	O
restricted	O
epitope	I:C0003316
for	O
RV	O
-	I:C0318483
A16	I:C0318483
and	O
RV	O
-	I:C0318506
A39	I:C0318506
by	O
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
and	O
the	O
ability	O
for	O
RV	O
-	I:C0318483
A16	I:C0318483
-	O
specific	O
Th1	B:C0242632
cells	I:C0242632
to	O
proliferate	O
in	O
response	O
to	O
their	O
RV	O
-	I:C0318506
A39	I:C0318506
peptide	O
counterpart	O
.	O

Cross-reactivity	O
was	O
evidenced	O
by	O
identification	O
of	O
a	O
common	O
*	O
0401	O
-	O
restricted	O
epitope	I:C0003316
for	O
RV	O
-	I:C0318483
A16	I:C0318483
and	O
RV	O
-	I:C0318506
A39	I:C0318506
by	O
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
and	O
the	O
ability	O
for	O
RV	O
-	I:C0318483
A16	I:C0318483
-	O
specific	O
Th1	O
cells	I:C0242632
to	O
proliferate	O
in	O
response	O
to	O
their	O
RV	B:C0318506
-	I:C0318506
A39	I:C0318506
peptide	O
counterpart	O
.	O

Cross-reactivity	O
was	O
evidenced	O
by	O
identification	O
of	O
a	O
common	O
*	O
0401	O
-	O
restricted	O
epitope	I:C0003316
for	O
RV	O
-	I:C0318483
A16	I:C0318483
and	O
RV	O
-	I:C0318506
A39	I:C0318506
by	O
tetramer	O
-	I:C0242831
guided	I:C0242831
epitope	I:C0242831
mapping	I:C0242831
and	O
the	O
ability	O
for	O
RV	O
-	I:C0318483
A16	I:C0318483
-	O
specific	O
Th1	O
cells	I:C0242632
to	O
proliferate	O
in	O
response	O
to	O
their	O
RV	O
-	I:C0318506
A39	I:C0318506
peptide	B:C0030956
counterpart	O
.	O

The	O
preferential	O
persistence	O
of	O
high	O
-	O
frequency	O
Rhinovirus	B:C0035473
-	O
specific	O
memory	O
Th1	I:C0242632
cells	I:C0242632
that	O
recognize	O
a	O
limited	O
set	O
of	O
conserved	O
epitopes	O
likely	O
arises	O
from	O
iterative	O
priming	O
by	O
previous	O
exposures	O
to	O
different	O
RV	O
strains	I:C0035473
.	O

The	O
preferential	O
persistence	O
of	O
high	O
-	O
frequency	O
Rhinovirus	O
-	O
specific	O
memory	B:C0242632
Th1	I:C0242632
cells	I:C0242632
that	O
recognize	O
a	O
limited	O
set	O
of	O
conserved	O
epitopes	O
likely	O
arises	O
from	O
iterative	O
priming	O
by	O
previous	O
exposures	O
to	O
different	O
RV	O
strains	I:C0035473
.	O

The	O
preferential	O
persistence	O
of	O
high	O
-	O
frequency	O
Rhinovirus	O
-	O
specific	O
memory	O
Th1	I:C0242632
cells	I:C0242632
that	O
recognize	O
a	O
limited	O
set	O
of	O
conserved	O
epitopes	B:C0003316
likely	O
arises	O
from	O
iterative	O
priming	O
by	O
previous	O
exposures	O
to	O
different	O
RV	O
strains	I:C0035473
.	O

The	O
preferential	O
persistence	O
of	O
high	O
-	O
frequency	O
Rhinovirus	O
-	O
specific	O
memory	O
Th1	I:C0242632
cells	I:C0242632
that	O
recognize	O
a	O
limited	O
set	O
of	O
conserved	O
epitopes	O
likely	O
arises	O
from	O
iterative	O
priming	O
by	O
previous	O
exposures	O
to	O
different	O
RV	B:C0035473
strains	I:C0035473
.	O

